Dr. Jenny H. Papazian, MD

Dr. Papazian practices at Kaiser Permanente San Diego Medical Center in San Diego, California.

Dr. Papazian's NPI, 1255565321, was assigned on May 5, 2009. Dr. Papazian graduated from George Washington University School of Medicine and Health Sciences in 2009. Dr. Papazian holds California license A114625.

Dr. Papazian's primary practice is Kaiser Permanente San Diego Medical Center, at 9455 Clairemont Mesa Blvd, San Diego, CA 92123 in San Diego County. The practice phone is (619) 528-5000.

Dr. Papazian's primary practice is Kaiser Permanente San Diego Medical Center in San Diego, California. Dr. Papazian is also affiliated with Kaiser Permanente Zion Medical Center. The medical group on file is Southern California Permanente Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Papazian practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Papazian's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Papazian is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Papazian is licensed in California.

Dmand AI lists aneurysm, heart failure and low blood pressure among the conditions Dr. Papazian treats.

CMS data shows 36 Medicare services from Dr. Papazian across 2 procedure codes in 2024, for 54 Medicare patients. Medicare paid $870 for them.

CMS counts 54 Medicare patients who saw Dr. Papazian in 2024. The largest group is 65 to 74, with 25 patients. 74% of them have high blood pressure, and 69% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Papazian's median patient age at 62, with 59% women.

In 2024, Dr. Papazian wrote 4,424 Medicare Part D claims for 836 patients. 81% of them were for generic drugs. CMS names the drug for 4,293 of them, across 38 drugs with 11 or more claims each, at $780,448 in total drug cost. In 2023, CMS named 3,870 claims across 37 drugs.

Dr. Papazian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Papazian, published from 2012 to 2015. 2012 was the busiest year, with 3. Dr. Papazian's most frequent co-authors are Harpreet Singh Bhatia, MAS, MD, Matthew J. Budoff, MD and Ronald P. Karlsberg, MD.

CMS Open Payments shows 35 general payments to Dr. Papazian from 16 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $780.

Dr. Papazian graduated from George Washington University School of Medicine and Health Sciences in 2009.

Dr. Papazian is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.